You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

68 Results
Guidelines and Advice
Guidelines and Advice
Mar 2014
Statistical Reports
Statistical Reports
Guidelines and Advice
Status: Current
ID: GL-C50-15
Jun 2014
Drug
Other Name(s): Trelstar® (Allergan Pharma)
Oct 2014
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Intent: Neoadjuvant, Adjuvant
Updated
Apr 2026
Regimen
Cancer Type:
Head and Neck, 
Nasopharynx
Intent: Palliative
Updated
Apr 2026

Pages